Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Alamar Biosciences, Inc.NASDAQ: ALMR

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development of $13.82M in Q2 FY2026

Q2 FY2026 research & development was $13.82M.

Context

  • Research & development amounted to 50.5% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$13.82M+6.1% QoQ
Last fiscal yearDec 2025
$37.47M— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
37.47M USD
Year-over-year change
—

Research & Development vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 research & development of $37.47M is the 8th highest of the 9 companies compared; the peer median is $63.18M.
  • Research & development amounts to 50.5% of revenue for ALMR, versus a peer median of 36.0%.
ALMR Competitors Peer median
Research & Development for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TXG10x Genomics, Inc.LTM Sep 2026$222.54M -10.9%-3.5%36.0%
TECHBio-Techne CorporationLTM Sep 2026$96.87M -3.0%+0.8%7.9%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$87.86M -27.1%-20.4%54.9%
TWSTTwist Bioscience CorporationLTM Sep 2026$71.84M -10.5%-12.4%15.6%
QSIQuantum-Si incorporatedLTM Mar 2026$54.53M -11.0%-9.3%2944.3%
SEERSeer, Inc.LTM Mar 2026$41.33M -11.2%-6.2%274.8%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$40.3M -12.6%+4.1%—
ALMRAlamar Biosciences, Inc.FY2025$37.47M ——50.5%
LABStandard BioTools Inc.LTM Mar 2026$22.48M -43.6%-11.4%26.1%
Peer median (excluding ALMR) $63.18M-11.1%-7.8%36.0%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.